Biotech attracted more venture capital than any other sector in the first quarter, with about $1.27 billion in funding, according to the MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association. The report noted that total venture capital investment only reached $7.1 billion during the period -- down 4.8% from last year -- due to difficult economic conditions.

Related Summaries